RxDoctor Payments Data

Cynthia Kucher, MD

Dermatopathology · New York, NYNPI 1134149685

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Botanix SB Inc accounts for 64.8% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $154, 6.9 times the $22 reported in 2019.

$193in general payments, 2019–2025

Across 4 payments — averaging $48.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Botanix SB Inc$125
  • Hologic Sales And Service, LLC$51
  • Leica Microsystems Inc.$16

What the payments were for

  • Food & beverage$193100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$193 in reported general payments places this provider in the 55th percentile of 44 dermatopathology providers in New York.

See all dermatopathology providers in New York

Medicare billing

Part B allowed, 2024
$559,932
Medicare patients
2,630
Services billed
6,353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatopathology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →